2015
Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis
McKee SA, Smith PH, Kaufman M, Mazure CM, Weinberger AH. Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis. Nicotine & Tobacco Research 2015, 18: 1002-1011. PMID: 26446070, PMCID: PMC5942618, DOI: 10.1093/ntr/ntv207.Peer-Reviewed Original ResearchConceptsSmoking cessation medicationsCessation medicationsSmoking cessationDouble-blind placebo-controlled trialEfficacy of vareniclinePlacebo-controlled trialShort-term outcomesClinical trial dataSex differencesSimilar ratesWeek 52Week 24Women smokersNicotine replacementWeek 12Outcome endpointsTherapeutic responseClinical trialsContinuous abstinenceVarenicline's efficacyVareniclinePlacebo outcomesEqual efficacySex disparitiesEffective FDA
2007
Timing and Predictors of Postpartum Return to Smoking in a Group of Inner‐City Women: An Exploratory Pilot Study
Letourneau AR, Sonja B, Mazure CM, O’Malley S, James D, Colson ER. Timing and Predictors of Postpartum Return to Smoking in a Group of Inner‐City Women: An Exploratory Pilot Study. Birth 2007, 34: 245-252. PMID: 17718875, DOI: 10.1111/j.1523-536x.2007.00177.x.Peer-Reviewed Original ResearchConceptsInner-city womenExploratory pilot studyPilot studyUrine cotinine levelsPostpartum hospital stayHealth supervision visitsPercent of womenTime of interviewPostpartum stayHospital stayWomen smokersCotinine levelsMonths postpartumPerinatal periodSupervision visitsPostpartum returnPregnancySmokingRelapse preventionGeneral equivalency diplomaWomenCigarettesSmokersStayAfrican Americans